Charles Bernick, MD, MPH, discusses efficacy, patient selection and safety surveillance for anti-amyloid agents.

Demitre Serletis, MD, PhD, details the current and future use of SEEG in the localization of seizure foci and surgical planning as part of a team that has completed more than 1,000 SEEG cases.

The incidence of behavioral health conditions in individuals with multiple sclerosis is four times higher than those with other neurological conditions. In this episode, Grace Tworek, PsyD, discusses the management of behavioral health conditions in MS.

Bill Clifton, MD, discusses the considerations and value of early intervention in adult idiopathic scoliosis.

Junaid Siddiqui, MD, details the four primary atypical parkinsonian disorders - PSP, MSA, DLB and CBD - and shares effective diagnostic techniques and management strategies, distinguishing them from Parkinson's disease.

Dan Ontaneda, MD, PhD, details the 2024 changes to the McDonald Criteria for multiple sclerosis diagnosis and discusses how these changes may impact and evolve the field.

Imad Najm, MD, explores why temporal lobe epilepsy is among the most challenging epilepsy types to treat and how gene therapy aims to overcome the challenges.

Amanda Horrigan, MD, provides guidance on diagnosing and managing schizophrenia through an empathetic and supportive approach.

Neuroendocrinologist, Divya Yogi-Morren, MD, and neurosurgeon, Pablo Recinos, MD detail the diagnostic work-up, medical management and surgical approaches used in pituitary disorders.

Alison Stout, DO, discusses the diagnostic complexity of axial lumbar back pain and the interventional treatment options currently available.